View of CORPORATE ENVIRONMENTAL DISCLOSURE, CORPORATE GOVERNANCE, AND COST OF DEBT IN CHINA’S PHARMACEUTICAL INDUSTRY

Return to Article Details CORPORATE ENVIRONMENTAL DISCLOSURE, CORPORATE GOVERNANCE, AND COST OF DEBT IN CHINA’S PHARMACEUTICAL INDUSTRY Download Download PDF